ERIC MUNCHRATH: Open Payments
NPI 1235592890 · WALLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 55 payments from 21 companies in 2025. Trend: 2023 $7,022 · 2024 $2,822 · 2025 $1,992
Food & beverage: $1,992
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $271 |
| AstraZeneca Pharmaceuticals LP | 6 | $193 |
| Inspire Medical Systems, Inc. | 3 | $185 |
| Amgen Inc. | 4 | $162 |
| Boston Scientific Corporation | 2 | $138 |
| Axsome Therapeutics, Inc. | 2 | $137 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| KYOWA KIRIN, INC. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $116 |
| Dexcom, Inc. | 2 | $97 |
Products named: Ozempic, INSPIRE, AIRSUPRA, REPATHA, General - Vascular Intervention, VOQUEZNA, Epclusa, Auvelity.
Industry payments across TX — which companies pay providers there.
